Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-01-22 @ 1:38 PM
Study NCT ID:
NCT02259556
Status:
RECRUITING
Last Update Posted:
2016-01-28
First Post:
2014-10-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas
Sponsor:
Chinese PLA General Hospital
Organization: